LPL and familial hyperaldosteronism: Therefore, we compared the effects of three different lipid-lowering therapies (statins, ezetimibe, and colestimide) on LPL and EL mass in pre-heparin plasma (pre-heparin LPL and EL mass, respectively) in patients with FH.